1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow T Lymphoblastic Lymphoma: new trials by email Literature Review of T Lymphoblastic Lymphoma trials Research Report on T Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) AKR1C3-activated Prodrug AST-3424, Biopsy Procedure, Biospecimen Collection - Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | SWOG Cancer Research Network | 67 | 2021-02-08 | 2026-09-01 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Biopsy (1) · Specimen Handling (1)
SWOG Cancer Research Network (1)
United States (1)
Anjali S Advani (1)
U10CA180888 (1)